Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region

被引:92
作者
Ofek, Gilad [1 ]
McKee, Krisha [1 ]
Yang, Yongping [1 ]
Yang, Zhi-Yong [1 ]
Skinner, Jeff [2 ]
Guenaga, F. Javier [1 ]
Wyatt, Richard [1 ]
Zwick, Michael B. [3 ]
Nabel, Gary J. [1 ]
Mascola, John R. [1 ]
Kwong, Peter D. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA
[3] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSITION-STATE ANALOG; MONOCLONAL-ANTIBODIES; VENOM PHOSPHOLIPASE-A2; ENVELOPE GLYCOPROTEIN; ECTODOMAIN REGION; CRYSTAL-STRUCTURE; GP41; ECTODOMAIN; ANTI-GP41; 2F5; MEMBRANE;
D O I
10.1128/JVI.02257-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The membrane-proximal external region (MPER) of the HIV-1 gp41 transmembrane glycoprotein is the target of the broadly neutralizing antibody 2F5. Prior studies have suggested a two-component mechanism for 2F5-mediated neutralization involving both structure-specific recognition of a gp41 protein epitope and nonspecific interaction with the viral lipid membrane. Here, we mutationally alter a hydrophobic patch on the third complementarity-determining region of the heavy chain (CDR H3) of the 2F5 antibody and assess the abilities of altered 2F5 variants to bind gp41 and to neutralize diverse strains of HIV-1. CDR H3 alterations had little effect on the affinity of 2F5 variants for a peptide corresponding to its gp41 epitope. In contrast, strong effects and a high degree of correlation (P < 0.0001) were found between virus neutralization and CDR H3 hydrophobicity, as defined by predicted free energies of transfer from water to a lipid bilayer interface or to octanol. The effect of CDR H3 hydrophobicity on neutralization was independent of isolate sensitivity to 2F5, and CDR H3 variants with tryptophan substitutions were able to neutralize HIV-1 similar to 10-fold more potently than unmodified 2F5. A threshold was observed for increased hydrophobicity of the 2F5 CDR H3 loop beyond which effects on 2F5-mediated neutralization leveled off. Together, the results provide a more complete understanding of the 2F5 mechanism of HIV-1 neutralization and indicate ways to enhance the potency of MPER-directed antibodies.
引用
收藏
页码:2955 / 2962
页数:8
相关论文
共 48 条
[1]   The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes [J].
Alam, S. Munir ;
McAdams, Mildred ;
Boren, David ;
Rak, Michael ;
Scearce, Richard M. ;
Gao, Feng ;
Camacho, Zenaido T. ;
Gewirth, Daniel ;
Kelsoe, Garnett ;
Chen, Pojen ;
Haynes, Barton F. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (07) :4424-4435
[2]   Role of HIV membrane in neutralization by two broadly neutralizing antibodies [J].
Alam, S. Munir ;
Morelli, Marco ;
Dennison, S. Moses ;
Liao, Hua-Xin ;
Zhang, Ruijun ;
Xia, Shi-Mao ;
Rits-Volloch, Sophia ;
Sun, Li ;
Harrison, Stephen C. ;
Haynes, Barton F. ;
Chen, Bing .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) :20234-20239
[3]   4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues [J].
Alving, Carl R. .
AIDS, 2008, 22 (05) :649-651
[4]   Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion [J].
Barbato, G ;
Bianchi, E ;
Ingallinella, P ;
Hurni, WH ;
Miller, MD ;
Cilibertol, G ;
Cortese, R ;
Bazzo, R ;
Shiver, JW ;
Pessi, A .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 330 (05) :1101-1115
[5]   A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates [J].
Barouch, DH ;
Yang, ZY ;
Kong, WP ;
Korioth-Schmitz, B ;
Sumida, SM ;
Truitt, DM ;
Kishko, MG ;
Arthur, JC ;
Miura, A ;
Mascola, JR ;
Letvin, NL ;
Nabel, GJ .
JOURNAL OF VIROLOGY, 2005, 79 (14) :8828-8834
[6]   Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C [J].
Binley, James M. ;
Lybarger, Elizabeth A. ;
Crooks, Emma T. ;
Seaman, Michael S. ;
Gray, Elin ;
Davis, Katie L. ;
Decker, Julie M. ;
Wycuff, Diane ;
Harris, Linda ;
Hawkins, Natalie ;
Wood, Blake ;
Nathe, Cory ;
Richman, Douglas ;
Tomaras, Georgia D. ;
Bibollet-Ruche, Frederic ;
Robinson, James E. ;
Morris, Lynn ;
Shaw, George M. ;
Montefiori, David C. ;
Mascola, John R. .
JOURNAL OF VIROLOGY, 2008, 82 (23) :11651-11668
[7]   The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20 [J].
Biron, Z ;
Khare, S ;
Quadt, SR ;
Hayek, Y ;
Naider, F ;
Anglister, J .
BIOCHEMISTRY, 2005, 44 (41) :13602-13611
[8]   A monomeric 310-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41 [J].
Biron, Z ;
Khare, S ;
Samson, AO ;
Hayek, Y ;
Naider, F ;
Anglister, J .
BIOCHEMISTRY, 2002, 41 (42) :12687-12696
[9]   Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications [J].
Bryson, Steve ;
Julien, Jean-Philippe ;
Hynes, Rosemary C. ;
Pai, Emil F. .
JOURNAL OF VIROLOGY, 2009, 83 (22) :11862-11875
[10]   Structural Constraints Imposed by the Conserved Fusion Peptide on the HIV-1 gp41 Epitope Recognized by the Broadly Neutralizing Antibody 2F5 [J].
de la Arada, Igor ;
Julien, Jean-Philippe ;
de la Torre, Beatriz G. ;
Huarte, Nerea ;
Andreu, David ;
Pai, Emil F. ;
Arrondo, Jose L. R. ;
Nieva, Jose L. .
JOURNAL OF PHYSICAL CHEMISTRY B, 2009, 113 (41) :13626-13637